Company Performance Metrics
Arun Duggal: Jubilant PharmaPast Role: HCLTech, Chief Financial Officer
Jubilant Pharma Limited is a company committed to providing solutions to the pharmaceuticals industry across the value chain. It is a subsidiary of Jubilant Life Sciences, an integrated global pharmaceutical and life sciences company.
The Company provides solutions to global pharmaceutical customers, offering a wide range of products &
services. Jubilant Pharma , is engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile and Non-sterile products through six USFDA approved manufacturing facilities in India, USA and Canada.
The Company’s success is an outcome of extensive research and development in the pharmaceutical space, which enabled it to move up the pharmaceutical value chain for products and services across geographies. Jubilant has been constantly investing in various growth platforms thereby promoting a culture of innovation.
At Jubilant Pharma, it is constant endeavours to improve the products and processes, to elevate the quality of production and cost competitiveness and to build value for its customers.
The Company has amplified the business by building capabilities internally, through strategic expansions and acquisitions, thereby, developing network of world class manufacturing facilities in India (two) and in North America (four). Headquartered in Singapore it has a dedicated team of around 4300 people across the globe and has extended its reach globally with ground presence in India, North America and Europe.
Jubilant Pharma’s progress in diverse businesses is a result of extensive R&D. Innovation at Jubilant is backed by strong chemistry, bio science expertise and the panoptic knowledge acquired over the years. The Company has strengths in R&D through a strong scientific team, modern facilities, command over affordable technologies and economies of scale into a synergistic organic entity, thereby, continuously developing and nurturing high quality products and technologies.
In line with Jubilant’s persistent focus on sustainability of business, it strives to improve stakeholder value through improved eco-efficient use of capital and natural resources. In the Company’s approach to sustainable development, the stress is laid on the triple bottom line of - Economics, Environment and Social performance. Jubilant Pharma has also pledged towards working on various areas for energy conservation and climate change mitigation.
